Cyclopropanecarboxylic acid → HCID 58117700, compound
Reaction equation
[CH:1]1([C:4]([OH:6])=O)[CH2:3][CH2:2]1.C(N(C(C)C)CC)(C)C.[CH2:16]1[C:22]2[CH:23]=[CH:24][C:25]([O:27][CH:28]3[CH2:33][CH2:32][N:31]([C:34]([O:36][C:37]([CH3:40])([CH3:39])[CH3:38])=[O:35])[CH2:30][CH2:29]3)=[CH:26][C:21]=2[CH2:20][CH2:19][NH:18][CH2:17]1>CN(C)C=O>[CH:1]1([C:4]([N:18]2[CH2:19][CH2:20][C:21]3[CH:26]=[C:25]([O:27][CH:28]4[CH2:33][CH2:32][N:31]([C:34]([O:36][C:37]([CH3:40])([CH3:39])[CH3:38])=[O:35])[CH2:30][CH2:29]4)[CH:24]=[CH:23][C:22]=3[CH2:16][CH2:17]2)=[O:6])[CH2:3][CH2:2]1Participants
5
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
16 l cyclopropylcarboxylic acid are placed in 3 ml dimethylformamide, then 174 l diisopropylethylamine and 93.1 mg O-(7-azabenzotriazol-1-yl-)-N,N,N′,N′-tetramethyluronium hexafluorophosphate (HATU) are added. After 15 min 77.5 mg tert-butyl 4-(2,3,4,5-tetrahydro-1H-benzo[d]azepin-7-yloxy)-piperidine-1-carboxylate are added. The reaction mixture is stirred at ambient temperature until there is no further reaction and the product is purified directly by preparative HPLC (method B). 70 mg of the product are obtained as a solid. Analytical HPLC-MS (method D): RT=1.37 min.
Workup
- customno further reaction
- customthe product is purified directly by preparative HPLC (method B)
Sources & evidence
- ORD record
- ord-d1a98260e42e4f9bab7aa28a489625d6
- Source dataset
- uspto-grants-2014_06
- Patent number
- US08754073B2
Reaction notes
Loading…